No recent analyst price targets found for CAMX.ST.
Latest News for CAMX.ST
Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
/PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the US Food and Drug Administration (FDA) has accepted for review the resubmission of the New
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for CAMX.ST.
Senate Trading
No Senate trades found for CAMX.ST.
U.S. House Trading
No House trades found for CAMX.ST.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.